Genesco (GCO) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
8 Jul, 2026Executive summary
Annual Meeting scheduled for July 21, with key focus on board elections and company progress.
Proxy advisory firm ISS recommended voting for all nine incumbent director nominees, citing strong momentum and strategic progress.
Communication emphasizes business continuity and ongoing operational focus during the proxy process.
Voting matters and shareholder proposals
Shareholder Bradley Radoff nominated two candidates in opposition to the nine incumbent nominees.
Board unanimously recommends voting for only the nine incumbent nominees using the WHITE proxy card.
ISS found no compelling case for board change and supports the current nominees.
Board of directors and corporate governance
Board consists of nine nominees supported by both the board and ISS.
Board Chair, President, and CEO Mimi E. Vaughn leads communication and governance efforts.
Latest events from Genesco
- Proxy advisors unanimously back all nine directors, supporting current strategy and board oversight.GCO
Proxy filing - Board urges support for its refreshed, diverse slate to sustain strategic momentum and value.GCO
Proxy filing - ISS backs all nine incumbent directors; board urges support against dissident nominees.GCO
Proxy filing - Strong sales growth, digital gains, and board stability drive long-term value creation.GCO
Proxy filing - Shareholders are asked to support nine board nominees to maintain momentum and protect value.GCO
Proxy filing - Proxy contest seeks board refreshment and governance reform, urging votes for two independent nominees.GCO
Proxy filing - Board urges support for its nominees, citing strong results and risks from activist candidates.GCO
Proxy filing - Q3 sales and comps beat expectations, raising FY25 guidance despite a tax-driven net loss.GCO
Q3 2025 - Q1 sales rose 4% to $474M, with 5% comp growth and reaffirmed full-year EPS guidance.GCO
Q1 2026